US OptionsDetailed Quotes
RIGL241220C18000
- 6.68
- 0.000.00%
15min DelayTrading Dec 10 10:00 ET
0.00High0.00Low
0.00Open6.68Pre Close0 Volume2 Open Interest18.00Strike Price0.00Turnover807.26%IV29.08%PremiumDec 20, 2024Expiry Date1.12Intrinsic Value100Multiplier4DDays to Expiry5.56Extrinsic Value100Contract SizeAmericanOptions Type0.6899Delta0.0217Gamma2.86Leverage Ratio-0.7653Theta0.0007Rho1.97Eff Leverage0.0071Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet